harvardbioscience.com (HBIO) - Gunggung Aset Perusahaan

The market value dynamics of Harvard Bioscience (HBIO) on the GURU.Markets platform, which currently stands at 78.15, highlight the scaling potential through the production of unique, high-margin laboratory equipment. The business relies on supplying cell analysis tools to global universities and biopharma behemoths, ensuring resilience against patent risks. Long-term subscriptions for electrophysiological instruments and pumps guarantee a stable cash flow.

Total Aset Perusahaan Harvard Bioscience Inc. (HBIO): kanggo periode 04.07.2022 - 28.10.2026

Rincian metrik komprehensif lan analitis Harvard Bioscience (HBIO)

- rega lan prakiraan konsensus rega:

Rega bursa Harvard Bioscience Inc.|HBIO - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Harvard Bioscience, Inc.|HBIO - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Aset Bersih saben Saham Harvard Bioscience|HBIO - Kapitalisasi Buku|Rasio Kapitalisasi marang Nilai Buku harvardbioscience.com|HBIO - Total Aset Perusahaan

- data utang lan likuiditas:

Koefisien Total Utang marang Modal Harvard Bioscience|HBIO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas harvardbioscience.com|HBIO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Harvard Bioscience, Inc.|HBIO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Harvard Bioscience

Pambiji fundamental:Harvard Bioscience Inc., HBIO

Produk asil prodhuksi Harvard Bioscience, Inc.

Total assets, reverse-calculated via ROA, reflect the dynamics of the company's aggregate resources, allowing investors to identify hidden cycles of capital expansion and contraction. By analyzing the changes in the financial assets of Harvard Bioscience (HBIO), one can assess the resilience of its B2B model, where the material base for producing biological research tools provides the foundation for long-term contracts with universities and pharma behemoths.

Pesaing utama